ADMINISTRATION DE MÉDICAMENT CIBLÉE SUR L'HÉMOGLOBINE POUR LE TRAITEMENT DU CANCER

• 收藏
• 分享

专利权人:

Therapure Biopharma Inc.

发明人:

BROOKES, Steven,ADAMSON, J. Gordon,BELL, David

申请号：

EP17814862

公开号：

EP3471775A4

申请日:

2017.06.21

申请国别(地区):

EP

年份:

2020

代理人:

摘要：

The use of hemoglobin as a targeting carrier for drugs is disclosed. Such hemoglobin-drug complexes have utility in the treatment of cancer, in particular cancers of the liver and colon. Said drug is preferably a nucleoside analog, in particular floxuridine and is covalently attached to the hemoglobin in a molar drug ratio of between 1 and 20.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/